Replies

The five drugs and treatments summarized below. There is lots more information at the linked article on Jerusalem Post.

1. The antiparasitic agent Ivermectin
Sheba’s Schwartz, a tropical disease expert, recently told the Post that he has new proof that ivermectin, which has been used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus.

Last week, he completed a double-blind, placebo-controlled study of 100 people with mild-to-moderate cases of COVID-19 that tested whether ivermectin could shorten the viral shedding period, allowing them to test negative for coronavirus and leave isolation in only a few days.

According to his still unpublished data, Schwartz said, the drug was shown to help “cure” people of the virus within just six days. Moreover, the chances of testing negative for coronavirus were three times higher for the group that received ivermectin than the placebo, he said.

2. Treating the full spectrum of COVID patients
Tel Aviv-headquartered RedHill Biopharma, a specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases, is now in the midst of late-stage clinical trials for two coronavirus treatments on hundreds of patients. The first focuses on early-stage cases and the second on treating hospitalized serious disease.

“Together, we can treat the full spectrum of coronavirus patients,” said the company’s chief operating officer, Gideon Raday.

“RedHill is unique, even relative to the world’s largest pharmaceutical companies, in that it is rapidly advancing not one but two Phase III-stage, orally administered, novel molecules for the treatment of COVID-19: RHB-107 for outpatient use and Opaganib for hospitalized patients,” explained CEO Dror Ben-Asher. “With these two promising and complementary shots on goal across the disease severity spectrum, RedHill is positioned at the very forefront of COVID-19 therapeutic research, aiming to address both existing and emerging mutations.”

3. All about Allocetra
Nineteen out of 21 COVID-19 patients in severe and critical condition were able to leave the hospital within a week after being administered an innovative treatment developed by researchers at Hadassah-University Medical Center.

Allocetra, the brainchild of Prof. Dror Mevorach – director of Hadassah’s internal medicine and coronavirus departments – is meant to treat a wide range of cases in which there is an overreaction of the immune system, which leads to an increase in the secretion of proteins by cells of the immune system called cytokines, and causes a cytokine storm.

A cytokine storm is when the immune system essentially goes into overdrive and begins attacking healthy cells. Mevorach has been researching the mechanism of how “dying cells” are handled in the body for 20 years, discovering that the body responds to these cells by down-regulating inflammation.

“I collect white blood cells from healthy donors. After engineering them to be in a dying state, I infuse them into the patients with COVID-19, patients who are in severe or critical condition, who are in the cytokine storm phase of the disease,” Mevorach explained. “Soon after I infuse them, they interact with the master regulator of the storm, called the macrophage. They reprogram the macrophage to be much more relaxed.”

4. Tel Aviv’s “miracle” cure
Since Tel Aviv’s Sourasky Medical Center announced earlier this month that it managed to “cure” 29 out of 30 moderate-to-severe COVID-19 patients who were administered a treatment developed by the hospital, it has received international attention.

The patients, who were part of a Phase I trial, recovered from the disease and were released within three to five days, according to Prof. Nadir Arber, whose lab developed the treatment. Since then, another five patients have received it, showing the same results.

The patients were given Arber’s EXO-CD24 COVID-19 treatment, which is based on CD24-enriched exosomes and is meant to fight the cytokine storm. Exosomes are responsible for cell-to-cell communication. In this case, they deliver the CD24 protein to the lungs, which helps calm down the immune system.

Arber said that a cytokine storm develops in between 5% and 7% of COVID-19 patients within five to seven days.

5. Wrestling back control from COVID
Finally, Hebrew University’s Nahmias believes he could downgrade COVID-19’s severity into nothing worse than a common cold, by using the FDA-approved drug Fenofibrate. His technology, licensed by Tissue Dynamics, a drug development company, permits rapid discovery of new therapeutics. “Viruses are parasites,” Nahmias explained. “They cannot replicate by themselves. They have to get inside a human cell and hijack their machinery to replicate.”

Nahmias research with collaborators at Mount Sinai Hospital demonstrated that the novel coronavirus prevents the burning of fat in lung cells, resulting in large amounts of fat accumulating inside lung cells – a condition the virus needs to reproduce. Fenofibrate, according to his published data, reversed that effect and eliminated virus replication in less than five days of treatment. “By understanding how the SARS-CoV-2 controls our metabolism, we can wrestle back control from the virus and deprive it of the very resources it needs to survive,” Nahmias said, noting that it also may help explain why patients with high blood sugar and cholesterol levels are often at a particularly high risk to develop COVID-19.

Nahmias, working with Sourasky and Hadassah medical centers, gathered and evaluated retrospective data on over 20,000 patients. This data showed the several dozen COVID-19 patients who were taking fibrates were protected from the virus, confirming his laboratory results

[NOTE: Fenofibrate is often prescribed for high cholesterol. Common drug names include Tricor, Lofibra, Antara, Triglide, Lipofen, and Fenoglide]

Ha! I’ve been pushing Ivermectin here for at least a couple months at this point.

Here’s my Ivermectin text block:

IANAD or public health professional, but my understanding is that technically, the vaccines are not “approved”, but rather have “emergency use authorizations.” These EUAs could only be granted if there were no available effective therapeutics. So the FedGov public health establishment had to refuse to recognize the efficacy of HCQ and Ivermectin-based therapies in order to be able to grant those EUAs. By doing this, they greatly increased the death and suffering due to Covid.

If we had a public health edifice that was worth anything, front line health care workers and public-facing store employees would be on Covid prophylaxis. The Federal public health agencies (FDA/NIH/CDC) have seemingly completely ignored cheap effective re-purposed therapeutics that could have significantly reduced deaths and transmission.

Ivermectin is effective for COVID-19: meta analysis of 35 studies
https://ivmmeta.com/

Front Line COVID-19 Critical Care Alliance
https://covid19criticalcare.com/
Key protocols from this group use Ivermectin.

COVID Care for Clinicians
https://www.evms.edu/covid-19/covid_care_for_clinicians/
Ditto this group.

India has been using HCQ and Ivermectin for many months as therapeutics and for prophylaxis. Their curves are quite impressive, scroll down to see them here.
https://www.worldometers.info/coronavirus/country/india/
Anyone able to interpret a basic graph will be impressed. Why is this not being talked about in Western media?

Also from India:
Ziverdo Kit Contains Zinc Acetate 50 mg, Doxycycline 100 mg & Ivermectin 12 mg Dispersible Tablets. It is currently indicated in the first line treatment for COVID-19 positive patients. Quadruple Therapy with Ivermectin is effective in treating COVID-19
https://www.rxindia.com/medicines/medicines-by-therapeutic-class/covid-19/ziverdo-kit/
That’s a link to an Indian online pharmacy selling that Covid treatment kit for under $2, just add vitamin D3.

Also, the meta-study link has links to a number of other studies. Here’s the one for HCQ.

HCQ is effective for COVID-19 when used early: real-time meta analysis of 197 studies
https://hcqmeta.com/

I continue to think the FedGov’s handling of these therapeutics criminal.

Israeli scientists and researchers are racing to find a cure for COVID-19, as global consensus is forming among medical professionals that vaccination is not going to eliminate corona.

And the reason is

• COVID-19 “vaccines” do not impart immunity or inhibit transmissibility of the disease. In other words, they are not designed to keep you from getting sick with SARS-CoV-2; they only are supposed to lessen your infection symptoms if or when you get infected. As such, these products do not meet the medical definition of a vaccine

• As of February 4, 2021, the U.S. Vaccine Adverse Event Reporting System (VAERS) has received 12,697 injury reports following COVID-19 vaccination and 653 deaths

• University of Oxford, which is collaborating on a COVID-19 vaccine with AstraZeneca, is now enrolling children between the ages of 6 years and 17 years and 8 months in their U.K. vaccine trial

• Moderna started testing its RNA-based gene therapy on American children between the ages of 12 and 17 in December 2020, and the first Pfizer trials involving adolescents began in mid-October 2020. In China, Sinovac and SinoPharm trials have been enrolling children as young as 3

• Children do not need a COVID-19 vaccine as they are at extremely low risk of severe COVID-19 and are not a significant vector of infection

As of February 4, 2021, the U.S. Vaccine Adverse Event Reporting System (VAERS) had received 12,697 injury reports and 653 deaths following COVID-19 vaccination.1
Of the cases reported between December 14, 2020, and February 4, 2021, 3.69% were life threatening and the number of deaths account for 5.14% of the total reports. The Pfizer vaccine accounted for 58% of deaths; Moderna’s accounted for 41%.

What’s more, when you look at vaccine-related deaths between January 2020 and January 2021, you find that COVID-19 vaccines account for a staggering 70% of the annual vaccine deaths, and that’s while having been available for less than two months. The first doses of Pfizer vaccine were given in mid-December 2020,2 while Moderna’s vaccine rolled out during the last week of December 2020.3 While these numbers are staggering, they’re likely only a tiny fraction of the actual number of adverse events. According to a U.S. Department of Health and Human Services study,4 fewer than 1% of vaccine adverse events are ever reported to VAERS.

This is primarily because VAERS reporting is voluntary. Many don’t even know it exists, or that you don’t have to be a medical professional to file a report. This would mean that there may, in reality, be over 1 MILLION COVID vaccine injuries, since 99% typically go unreported